T · 8113.T · HOUSEHOLD & PERSONAL PRODUCTS
Unicharm Corporation (8113.T) intrinsic value and stock valuation
$1,085.50as of 2026-11-21 · Mkt cap 1.64T
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Unicharm Corporation DCF and intrinsic value
InvestorsCraft values 8113.T with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from 8113.T’s statements →
Unicharm Corporation Graham Number
Graham Number: $654.17d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $945.3B | $989B | $941.8B | $898B | $782.7B |
| Operating income | $108.9B | $138.5B | $128B | $119.6B | $122.5B |
| Net income | $65.2B | $81.8B | $86.1B | $67.6B | $72.7B |
| EPSd | $37.3M | $46.4M | $48.5M | $37.9M | $40.6M |
| Operating cash flow | $131.5B | $137.1B | $162.4B | $92.2B | $105.3B |
| Capital expenditure | -$-28.63B | -$-39.33B | -$-38.41B | -$-32.95B | -$-34.67B |
| Free cash flow | $102.8B | $97.8B | $124B | $59.3B | $70.6B |
| Total assets | $1.22T | $1.24T | $1.13T | $1.05T | $987.7B |
| Total debt | $11.1B | $61.8B | $61.3B | $57.1B | $75.5B |
| Net debt | -$-242.04B | -$-199.23B | -$-192.43B | -$-160.03B | -$-112.08B |
| Total equity | $891.3B | $873.7B | $788.3B | $708.6B | $635.4B |
| Cash and short-term investments | $253.1B | $353.9B | $334.4B | $293B | $293.1B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $945.3B | $989B | $941.8B | $898B | $782.7B |
| Cost of revenue | $589.4B | $612.6B | $601.4B | $579.8B | $479.6B |
| Gross profit | $355.9B | $376.4B | $340.4B | $318.2B | $303.1B |
| Research and development expenses | $13.6B | $10.3B | $9.82B | $8.27B | $8.18B |
| Selling, general and administrative expenses | $233.4B | $227.6B | $202.6B | $190.4B | $172.4B |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $247B | $237.9B | $212.4B | $198.7B | $180.6B |
| Cost and expenses | $836.4B | $850.5B | $813.8B | $778.5B | $660.2B |
| Interest income | $7.34B | $8.77B | $5.76B | $3.8B | $3.02B |
| Interest expense | $3.93B | $3.24B | $3.51B | $2.8B | $1.51B |
| Depreciation and amortization | $47.8B | $46.5B | $43.3B | $41.5B | $37.9B |
| Ebitda | $156.7B | $185B | $171.2B | $161.1B | $160.4B |
| Operating income | $108.9B | $138.5B | $128B | $119.6B | $122.5B |
| Total other income/expenses, net | -$-3.5B | -$-3.93B | $4.33B | -$-3.86B | -$-506M |
| Income before tax | $105.4B | $134.5B | $132.3B | $115.7B | $122B |
| Income tax expense | $34.5B | $39.3B | $34.3B | $37.3B | $38.4B |
| Net income | $65.2B | $81.8B | $86.1B | $67.6B | $72.7B |
| Weighted average shares outstanding | $1.75B | $1.76B | $1.78B | $1.79B | $1.79B |
| Weighted average diluted shares outstanding | $1.75B | $1.76B | $1.78B | $1.79B | $1.79B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $253.1B | $353.9B | $334.4B | $293B | $293.1B |
| Net receivables | $154.8B | $168.6B | $151.6B | $153B | $129.4B |
| Inventory | $123.3B | $121.1B | $103B | $117.6B | $89.8B |
| Total current assets | $641.6B | $671B | $638.9B | $603.8B | $547.7B |
| Property, plant and equipment, net | $275.7B | $293.2B | $285.6B | $271.7B | $271.7B |
| Goodwill and intangible assets | $97.1B | $101.1B | $95.7B | $90.5B | $85.4B |
| Long-term investments | $180.2B | $136.2B | $90.7B | $66.4B | $66.8B |
| Total non-current assets | $581.5B | $568.9B | $494.7B | $445.5B | $439.9B |
| Total assets | $1.22T | $1.24T | $1.13T | $1.05T | $987.7B |
| Accounts payable | $221.6B | $131.3B | $125.2B | $127.9B | $121.5B |
| Short-term debt | $3.49B | $27.7B | $20.9B | $17.1B | $39.3B |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $263.9B | $301.6B | $270.1B | $256.7B | $274.5B |
| Long-term debt | $7.57B | $34.1B | $40.4B | $40.1B | $36.2B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $68B | $64.7B | $75.3B | $83.9B | $77.8B |
| Capital lease obligations | $0.00 | $28.3B | $26.8B | $23.8B | $31.8B |
| Total liabilities | $331.9B | $366.3B | $345.4B | $340.6B | $352.2B |
| Common stock | $16B | $16B | $16B | $16B | $16B |
| Retained earnings | $801.4B | $766.3B | $710.8B | $644.9B | $599.9B |
| Accumulated other comprehensive income (loss) | $106.2B | $98.7B | $59.2B | $26.5B | -$-4.45B |
| Total equity | $891.3B | $873.7B | $788.3B | $708.6B | $635.4B |
| Total investments | $180.2B | $229.1B | $171.3B | $142.2B | $172.3B |
| Total debt | $11.1B | $61.8B | $61.3B | $57.1B | $75.5B |
| Net debt | -$-242.04B | -$-199.23B | -$-192.43B | -$-160.03B | -$-112.08B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $65.2B | $81.8B | $86.1B | $67.6B | $72.7B |
| Depreciation and amortization | $47.8B | $46.5B | $43.3B | $41.5B | $37.9B |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $13.2B | -$-565M | $22.3B | -$-35.93B | -$-24.41B |
| Accounts receivable | $13.6B | -$-9.38B | $8.27B | -$-22.91B | -$-4.72B |
| Inventory | -$-1.92B | -$-12.13B | $20.7B | -$-22.47B | -$-23.15B |
| Accounts payable | -$-8.67B | $15.7B | -$-12.33B | -$-1.27B | $14.2B |
| Net cash provided by operating activities | $131.5B | $137.1B | $162.4B | $92.2B | $105.3B |
| Investments in property, plant and equipment | -$-28.63B | -$-39.33B | -$-38.41B | -$-32.95B | -$-34.67B |
| Acquisitions, net | $2.13B | $76M | -$-10.23B | $2.91B | $664M |
| Net cash used for investing activities | -$-55.94B | -$-73.84B | -$-67.45B | -$-4.28B | -$-79.84B |
| Common stock issued | $0.00 | $0.00 | $0.00 | $1.91B | $1.9B |
| Common stock repurchased | -$-22B | -$-19B | -$-17B | -$-17B | -$-16B |
| Dividends paid | -$-28.65B | -$-24.7B | -$-23.1B | -$-22.05B | -$-20.3B |
| Net cash used for financing activities | -$-86.64B | -$-66.79B | -$-67.09B | -$-64.52B | -$-45.18B |
| Net change in cash | -$-7.96B | $7.28B | $36.6B | $29.6B | -$-11.98B |
| Cash at end of period | $253.1B | $261.1B | $253.8B | $217.2B | $187.5B |
| Operating cash flow | $131.5B | $137.1B | $162.4B | $92.2B | $105.3B |
| Capital expenditure | -$-28.63B | -$-39.33B | -$-38.41B | -$-32.95B | -$-34.67B |
| Free cash flow | $102.8B | $97.8B | $124B | $59.3B | $70.6B |
Line items
Line items
Line items
About Unicharm Corporation
Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.
- CEO
- Takahisa Takahara
- Employees
- 1.4K
- Beta
- 0.25
Included in
Explore
Frequently asked questions
What is the intrinsic value of Unicharm Corporation (8113.T)?
InvestorsCraft does not currently publish an intrinsic value for 8113.T. How the IC value is calculated.
Is 8113.T undervalued?
InvestorsCraft does not publish an undervaluation signal for 8113.T at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.